| Composition | Amikacin Sulphate |
|---|---|
| Dosage | Injection |
| Packing Size | 25×2 ml |
| Packing | Vial |
AMIKACIA-500 Injection is a highly effective aminoglycoside antibiotic widely used in the treatment of severe bacterial infections. Containing amikacin sulfate 500mg, this injectable formulation provides strong antibacterial action against gram-negative bacteria, including resistant strains that are often difficult to manage with conventional antibiotics. AMIKACIA-500 Injection is trusted in hospitals and critical care settings for its rapid action, reliable results, and safety profile.
AMIKACIA-500 Injection contains amikacin, a powerful antibiotic that works by inhibiting bacterial protein synthesis, leading to the elimination of infection-causing bacteria. Its injectable form ensures quick absorption, fast onset of action, and high bioavailability, making it particularly useful in emergency and intensive care cases. Each vial is manufactured under stringent pharmaceutical standards, ensuring purity, potency, and consistent quality.
AMIKACIA-500 Injection is highly effective in treating respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, bone and joint infections, skin and soft tissue infections, and hospital-acquired infections. It is especially valuable in managing life-threatening conditions caused by multidrug-resistant organisms. Doctors prefer AMIKACIA-500 Injection in intensive care and post-surgical infection management due to its proven efficacy and dependable therapeutic action.
Choosing AMIKACIA-500 Injection means selecting a strong, fast-acting antibiotic solution trusted worldwide by healthcare professionals. It ensures effective bacterial eradication, reduced complications, and better patient recovery outcomes. With its reliable action against resistant pathogens, AMIKACIA-500 Injection remains one of the most preferred antibiotics in modern clinical practice.
AMIKACIA-500 Injection is the right choice for hospitals and healthcare providers seeking a safe, powerful, and result-driven injectable antibiotic therapy for critical bacterial infections.
